Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Evolent Health Inc

Healthcare US EVH

4.8USD
0.32(7.14%)

Last update at 2026-06-23T20:05:00Z

Day Range

4.434.91
LowHigh

52 Week Range

2.1012.06
LowHigh

Fundamentals

  • Previous Close 4.48
  • Market Cap351.66M
  • Volume1984161
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA88.22M
  • Revenue TTM1876.23M
  • Revenue Per Share TTM16.43
  • Gross Profit TTM 399.88M
  • Diluted EPS TTM-5.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -534.63600M -63.03600M -202.40500M -62.07700M -29.80100M
Minority interest - - - - 0.00000M
Net income -534.51000M -61.62300M -113.04000M -18.70100M -30.28400M
Selling general administrative 303.87M 263.05M 358.11M 245.75M 219.50M
Selling and marketing expenses - - - - -
Gross profit 283.03M 367.35M 460.47M 316.58M 250.41M
Reconciled depreciation 115.85M 118.37M 123.42M 67.19M 60.04M
Ebit -477.16500M -38.31400M -148.20000M -59.83500M 30.25M
Ebitda -361.31400M 84.85M -24.78500M 7.36M 90.28M
Depreciation and amortization 115.85M 123.17M 123.42M 67.19M 60.04M
Non operating income net other - - - 6.00M 13.59M
Operating income -4.43400M -40.48500M -71.21100M -59.83500M 30.25M
Other operating expenses 1880.66M 2595.23M 2035.11M 1371.89M 937.09M
Interest expense 57.47M 24.72M 54.20M 15.57M 25.43M
Tax provision -0.12600M -1.41300M -89.36500M -43.37600M 0.48M
Interest income 4.19M 5.54M 5.26M 9.63M 0.41M
Net interest income -53.28100M -19.17800M -48.94900M -14.20300M -25.01800M
Extraordinary items - 0.00000M 0.00000M -0.46300M -7.31700M
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.12600M -1.41300M -89.36500M -43.37600M 0.48M
Total revenue 1876.23M 2554.74M 1963.90M 1352.01M 907.96M
Total operating expenses 287.47M 407.84M 531.68M 336.46M 279.54M
Cost of revenue 1593.20M 2187.39M 1503.43M 1035.43M 657.55M
Total other income expense net -530.20200M -22.55100M -131.19400M -2.24200M -60.04900M
Discontinued operations - - - -0.46300M -7.31700M
Net income from continuing ops -534.51000M -61.62300M -113.04000M -18.70100M -30.28400M
Net income applicable to common shares -579.40100M -93.45400M -142.26000M -19.16400M -37.60100M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1899.24M 2544.41M 2680.31M 1817.29M 1419.46M
Intangible assets 584.94M 680.16M 752.01M 442.78M 279.78M
Earning assets - - - - -
Other current assets 31.12M 28.94M 44.10M 451.10M 435.30M
Total liab 1484.04M 1543.15M 1612.61M 957.88M 725.83M
Total stockholder equity 415.19M 1001.26M 1067.70M 859.42M 693.63M
Deferred long term liab - - - 4.74M 1.40M
Other current liab 308.94M 418.79M 610.28M 363.39M 330.40M
Common stock 1.18M 1.17M 1.15M 1.01M 0.91M
Capital stock 1.18M 1.17M 1.15M 1.01M 0.91M
Retained earnings -1315.32700M -780.81700M -719.19400M -606.15400M -626.77900M
Other liab - - - 55.44M 6.93M
Good will 694.48M 1137.32M 1116.54M 722.77M 426.30M
Other assets 19.32M 31.95M 33.01M 32.30M 52.39M
Cash 151.86M 104.20M 192.82M 188.20M 266.28M
Cash and equivalents 151.86M 104.20M 192.82M 188.20M 266.28M
Total current liabilities 385.26M 715.50M 674.24M 433.44M 445.49M
Current deferred revenue 1.20M 2.51M 5.98M 5.76M 11.94M
Net debt 837.84M 609.47M 451.97M 287.92M 14.19M
Short term debt 15.34M 198.18M 9.74M 7.12M 7.07M
Short long term debt - 171.47M - - -
Short long term debt total 989.70M 713.67M 644.80M 476.12M 280.47M
Other stockholder equity 1731.97M 1782.66M 1787.00M 1465.73M 1319.87M
Property plant equipment 85.16M 79.28M 90.18M 87.87M 81.36M
Total current assets 506.37M 607.12M 683.67M 478.05M 523.96M
Long term investments 8.97M 8.59M 4.89M 4.47M 5.46M
Net tangible assets - - - -306.14100M -12.44800M
Short term investments - 59.30M 13.77M 14.49M 75.69M
Net receivables 323.40M 414.68M 446.75M 254.68M 130.60M
Long term debt 970.54M 490.52M 597.05M 412.99M 215.68M
Inventory - - 0.00000M -415.92600M -308.22200M
Accounts payable 59.78M 96.03M 48.25M 57.17M 96.08M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2.62400M -1.75300M -1.25700M -1.17800M -0.36200M
Additional paid in capital - - - - -
Common stock total equity - - - 1.01M 0.91M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -606.15400M -626.77900M
Treasury stock - - - - -21.12300M
Accumulated amortization - - - - -
Non currrent assets other 19.32M 31.95M 33.01M 32.30M 12.98M
Deferred long term asset charges - - - - -
Non current assets total 1392.86M 1937.29M 1996.63M 1339.24M 895.50M
Capital lease obligations 19.16M 51.69M 47.75M 63.13M 64.79M
Long term debt total 970.54M 490.52M 597.05M 412.99M 215.68M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -62.93200M -413.94800M 36.52M 54.22M
Change to liabilities - - - -16.88600M 7.73M
Total cashflows from investing activities -0.23300M -62.93200M -415.54400M -259.11500M -15.78600M
Net borrowings 65.06M 58.58M 183.29M 219.74M -98.84900M
Total cash from financing activities -35.92400M -0.56500M 281.34M 131.54M -29.54800M
Change to operating activities - - - -8.11800M -14.37700M
Net income -579.40100M -61.62300M -113.04000M -19.16400M -37.60100M
Change in cash 14.49M -44.96100M 8.30M -139.78400M -6.63900M
Begin period cash flow 163.50M 223.46M 215.16M 354.94M 361.58M
End period cash flow 177.99M 178.50M 223.46M 215.16M 354.94M
Total cash from operating activities 38.84M 18.77M 142.58M -11.55300M 38.75M
Issuance of capital stock 0.00000M 0.00000M 168.00M - -
Depreciation 122.64M 125.61M 123.42M 67.19M 60.04M
Other cashflows from investing activities 34.85M -30.71800M -387.66900M -295.63600M -70.00500M
Dividends paid 11.13M 20.09M 18.79M -14.88400M -1.30000M
Change to inventory - - -10.74600M - -14.11600M
Change to account receivables 73.70M 32.06M -164.69400M -102.98000M -5.77900M
Sale purchase of stock -39.99600M -16.62400M -15.29200M -10.43200M 11.99M
Other cashflows from financing activities -49.86400M -42.51700M 116.84M 146.43M 70.60M
Change to netincome - - - -26.91400M 17.00M
Capital expenditures 34.09M 24.89M 28.75M 38.36M 24.98M
Change receivables - - - - -
Cash flows other operating - - - -18.08600M -26.46600M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -139.12700M -6.58700M
Change in working capital -57.38400M -116.55700M 21.89M -104.44100M -13.64500M
Stock based compensation 39.74M 39.75M 40.50M 33.98M 16.71M
Other non cash items 516.23M 34.40M 101.09M 10.53M 13.77M
Free cash flow 4.75M -6.12800M 113.84M -49.91400M 13.76M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EVH
Evolent Health Inc		 0.32 7.14% 4.80 - 16.29 0.19 0.79 0.62 88.49
VEEV
Veeva Systems Inc Class A		 6.55 4.28% 159.71 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.02 0.38% 5.23 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock		 -0.36 0.54% 66.84 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

View All

Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Evolent Health Inc

1812 N. Moore Street, Arlington, VA, United States, 22209

Key Executives

Name Title Year Born
Mr. Frank John Williams Co-Founder & Chairman 1966
Mr. Seth Barrie Blackley Co-Founder, CEO & Director 1979
Mr. John Paul Johnson Chief Financial Officer 1984
Mr. Steve Tutewohl FSA, MAAA Chief Operating Officer 1973
Mr. Aammaad Shams Chief Accounting Officer & Controller 1984
Mr. Jonathan David Weinberg J.D. Chief Legal Officer, Gen. Counsel & Sec. 1968
Mr. Dan McCarthy CEO of New Century Health & Pres NA
Mr. Seth R. Frank VP of Investor Relations NA
Ms. Jessica Somers Sr. VP of Corp. Devel. NA
Ms. Kali Beyah Chief People & Brand Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.